Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind intra-individual placebo-controlled trial of topical P144 in cutaneous fibrosis of systemic sclerosis
2007-002015-38Phase 2Active
- Sponsor
- ISDIN
- Start
- Jul 2007
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of disitertide in systemic sclerosis (SSc), sponsored by ISDIN. Primary endpoints: Soluble collagen content and Skin hardness (durometry). Started Jul 2007; status: active.
02
Drugs
disitertide
03
Conditions
systemic sclerosis (SSc)
Beyond the preview
Go deeper on 2007-002015-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002015-38.